Cipla collaborates with S&D Pharma
To enter Czech Republic and Slovakia with affordable high quality alternatives
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Roche and InterMune reach definitive merger agreement
Roche to fully acquire InterMune at a price of $74.00 per share
Wockhardt’s two anti-infective drugs get QIDP status from US FDA
WCK 771 is an intravenous (IV) drug while WCK 2349 is a solid oral tablet
Indian pharma excipients industry sets up IPEC India
IPEC India is the fifth member of the IPEC Federation
Novartis in pact with TB Alliance
As per agreement, NITD will fully transfer its TB R&D programme to TB Alliance
Cipla in agreement with Salix Pharmaceuticals
Cipla has granted Salix exclusive rights under certain patent applications in the ‘Rifaximin Complexes’ patent family
Strengthening product offerings to supplement existing portfolios drive M&A activity
Indian pharma sector witnesses no deals during August 2014
ABLE to host 11th edition of BIOINVEST
The event in Bangalore will discuss about the importance of investing in biotechnology in India
DIA to organise 9th Annual India Conference
It will be held in Mumbai from October 16-18, 2014; the theme for the event will be ‘The Future of Indian Healthcare: Patients,…